Cardiovascular Diseases Research in Washington
Cardiovascular Diseases Research (93.837) awarded $401 million to recipients in Washington in 280 grants from fiscal 2021 to 2025, 2.7% of the program's national total. University of Washington received the most, $241 million.
- Awarded in Washington$401 million
- Awards280
- Share of the program2.7%
- Rank among states11th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 162 | $83.9 million |
| FY 2022 | 162 | $85.8 million |
| FY 2023 | 153 | $82.3 million |
| FY 2024 | 143 | $73.6 million |
| FY 2025 | 120 | $75.8 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Washington | Colleges and universities | 185 | $241 million |
| Fred Hutchinson Cancer Center | Nonprofits | 30 | $89.8 million |
| Seattle Children's Hospital | Nonprofits | 28 | $33.8 million |
| Bloodworks | Nonprofits | 7 | $11.1 million |
| Washington State University | Colleges and universities | 4 | $4.6 million |
| Curi Bio Inc | Small businesses | 2 | $3.0 million |
| Battelle Memorial Institute | Nonprofits | 1 | $2.8 million |
| Virtici LLC | Small businesses | 1 | $2.7 million |
| Benaroya Research Institute at Virginia Mason | Nonprofits | 2 | $2.4 million |
| Healionics Corporation | Small businesses | 2 | $2.2 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Washington?
$401 million from fiscal 2021 to 2025, across 280 awards. Washington ranks 11th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Washington?
The largest recipient is University of Washington, with $241 million in 185 awards. Next are Fred Hutchinson Cancer Center and Seattle Children's Hospital.
Can organizations in Washington apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant